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Abstract
We report a genome-wide association (GWA) study of severe malaria in The Gambia. The initial
GWA scan included 2,500 children genotyped on the Affymetrix 500K GeneChip, and a replication
study included 3,400 children. We used this to examine the performance of GWA methods in Africa.
We found considerable population stratification, and also that signals of association at known malaria
resistance loci were greatly attenuated owing to weak linkage disequilibrium (LD). To investigate
possible solutions to the problem of low LD, we focused on the HbS locus, sequencing this region
of the genome in 62 Gambian individuals and then using these data to conduct multipoint imputation
in the GWA samples. This increased the signal of association, from P = 4 × 10−7 to P = 4 × 10−14,
with the peak of the signal located precisely at the HbS causal variant. Our findings provide proof
of principle that fine-resolution multipoint imputation, based on population-specific sequencing data,
can substantially boost authentic GWA signals and enable fine mapping of causal variants in African
populations.
The malaria parasite Plasmodium falciparum kills on the order of a million African children
each year1, and this is a small fraction of the number of infected individuals in the
population1-3. In communities where everyone is repeatedly infected with P. falciparum, host
genetic factors account for ~25% of the risk of severe malaria, that is, life-threatening forms
of the disease3. The strongest known determinant of risk, hemoglobin S (HbS), accounts for
~2% of the total variation, implying that only a small fraction of genetic resistance factors have
so far been discovered3. Identifying the genetic basis of protective immunity against severe
malaria may provide important insights for vaccine development.
Here we examine the possibility of approaching this problem by genome-wide association
(GWA) analysis. There are many unsolved methodological questions about how to conduct an
effective GWA study in Africa4. High levels of ethnic diversity may result in false-positive
associations owing to population structure. Variations in haplotype structure between different
ethnic groups may reduce power to detect GWA signals, particularly when data are
amalgamated across multiple study sites. Low LD implies the need for denser genotyping
arrays than are currently available: a crude estimate is that an African GWA study with 1.5
million SNPs would have approximately the same statistical power as a European study with
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0.6 million SNPs5, but this is based on HapMap data from a single ethnic group and a larger
number of SNPs may be needed to achieve adequate power across different ethnic groups.
We carried out an initial GWA study in Gambian children that explores these methodological
questions. Genotyping of ~500,000 SNPs was conducted on 1,060 cases of severe malaria and
1,500 population controls using the Affymetrix GeneChip 500K Mapping Array Set. The
results reported here are based on a set of 402,814 SNPs in 958 cases and 1,382 controls that
passed stringent quality control procedures. Access to these data may be requested online (see
URLs section in Methods).
RESULTS
Examining population structure
Subjects were recruited from an area of approximately 400 square miles in the Kombos region
of The Gambia. Four ethnic groups, Mandinka, Jola, Wolof and Fula, accounted for 89% cases
and 86% controls (Supplementary Table 1 online). Using Wright's FST across all autosomal
SNPs, we found that differences between ethnic groups accounted for a small fraction of genetic
variation within the population as a whole (FST = 0.004). The greatest differentiation was seen
between Fula and Jola (FST = 0.007) and the least between Mandinka and Wolof (FST = 0.002)
(Supplementary Table 2 online).
To investigate the relationship between population structure and self-reported ethnicity, we
carried out principal components analysis (PCA) of 100,715 SNPs, selected to reduce LD
between markers (Fig. 1)6. The first two principal components distinguished Fula and Jola,
and the third principal component separated the Mandinka and Wolof from others. Some
individuals could be confidently assigned to a specific ethnic group, whereas others seemed to
have a more complex ancestry. These findings were verified using the STRUCTURE7 program
on 8,000 SNPs, which gave an optimal model of population structure with four genetic
subpopulations corresponding to the four most common ethnic groups (Supplementary Fig.
1 online).
To place these findings in the context of global population structure, we compared the Gambian
sample with populations studied by the HapMap project5,8. The Gambian sample can be clearly
distinguished by PCA from the Yoruba people of Ibadan, Nigeria (a different part of West
Africa) but is much closer to Yoruba than to European, Han Chinese or Japanese samples (Fig.
2a). Individual ethnic groups within The Gambia seem to have greater genetic diversity than
the HapMap Yoruba sample (compare Fig. 1a with Fig. 2b, Supplementary Fig. 2 online).
This may reflect the fact that Gambian samples were recruited from the general population,
whereas the HapMap Yoruba samples were collected in a particular community from
individuals with four Yoruba grandparents.
Genome-wide association of severe malaria
To evaluate the likelihood of false-positive GWA findings due to population structure, we
conducted a trend test of association in cases versus controls on all SNPs, and compared
observed χ2 values to expected values under the null hypothesis in a quantile-quantile plot (Fig.
3). The overdispersion of association test statistics (λ = 1.23) implies a high number of false-
positive associations in the raw data, but this was greatly reduced by correction for self-reported
ethnicity (λ = 1.07), and became negligible when the first three principal components from the
eigenanalysis of population structure were entered as covariates in logistic regression analysis
(λ = 1.02). For comparison, λ has been estimated to be 1.03–1.11 in case-control studies in the
British population, a range considered acceptable for GWA analysis9. Thus, with appropriate
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statistical correction, false-positive GWA findings arising from the Gambian population
structure can be reduced to a very low level.
After PCA correction for population structure, we tested each SNP for disease association using
an unguided genotypic test with 2 degrees of freedom (d.f.), as well as tests with 1 d.f. for
models of dominance, recessiveness, heterozygous advantage and trend. Cluster plots were
visually inspected on all potentially significant results, which yielded 139 SNPs with
unequivocal genotype results in 100 independent regions of the genome with P< 10−4
(Supplementary Table 3 online), including 6 with P< 10−6 (Fig. 4). The strongest signal of
association was close to the HBB gene on chromosome 11p15, where the HbS polymorphism
is located, with 13 SNPs at P< 10−4 and a minimum of P = 3.9×10−7 by trend test. In following
sections, we examine the signal of association around the HbS polymorphism, evaluate other
known and putative malaria resistance–associated genes and describe newly identified signals
of association.
Fine-resolution association mapping at the HbS locus
HbS provides a benchmark for evaluating GWA methods, as the causal polymorphism
responsible for the malaria-protective effect is known: it is a SNP (rs334) in the coding region
of HBB on chromosome 11p15.4 which results in replacement of glutamic acid with valine at
amino-acid residue 6 of the β-globin chain. When we genotyped rs334 on the same samples
used in the GWA study, using the Sequenom iPlex platform, we found a much stronger signal
of association (P = 1.3 × 10−28). This raises several questions: why was the GWA signal (P =
3.9 × 10−7) much weaker than the true effect; is there an effective way to increase the GWA
signal; and is there an effective way to get from the GWA signal to identification of the causal
variant?
To investigate these questions, we sequenced 111 kb in the center of the GWA signal on
chromosome 11p15 in a reference panel of 62 randomly selected Gambian controls (see
Methods). These reference data were used to impute genotypes for all ~2,500 individuals in
the GWA study with the IMPUTE program10, and a trend test of association was conducted at
each imputed SNP. Out of 202 SNPs examined across this 111 kb region, three imputed SNPs
had stronger signals of association than any of the SNPs genotyped on the initial GWA scan
(Fig. 5). The HbS causal polymorphism (rs334) stands out as the imputed SNP with the
strongest association (P = 4.5×10−14), several orders of magnitude more significant than the
strongest signal from SNPs that were directly genotyped (P = 3.9×10−7).
This result provides proof of principle that it is possible to identify the causal polymorphism
within a GWA signal by regional sequencing followed by multipoint association mapping using
model-based imputation, provided the appropriate reference panel is used. We observed two
features of LD in this region of the genome in this population, which may together be favorable
for fine mapping. First, over a 1-Mb region we identified 55 SNPs with D' = 1 in relation to
the HbS causal polymorphism rs334 (Fig. 6): this is consistent with previous evidence that the
HbS allele is associated with an extended haplotype a result of recent positive selection5,11
Second, the region as a whole has weak LD with a well-known recombination hot spot12, and
the correlation between rs334 and neighboring SNPs does not exceed an r2 of 0.36 (Fig. 6). In
other words, there are no neighboring SNPs that are sufficiently strongly correlated with rs334
to imitate the true signal of association generated from the causal variant. We are still at an
early stage of understanding how the process of fine mapping is affected by different patterns
of natural variation in the human genome, and this example of extended haplotype within a
region of generally low LD provides an interesting case study.
In general, the performance of imputation strategies depends on the overall information content
the genotyped SNPs carry for the untyped SNPs in the region, which was estimated at only
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40% for rs334 for our data. This may explain, in part, why the imputed association signal (P
= 4.5×10−14) was weaker than the value obtained when we genotyped rs334 directly on the
same samples (P = 1.3×10−28).
The HapMap Yoruba sample has been used as the basis for designing GWA genotyping arrays
intended for African populations in general, and these data provide an example of where this
approach may fail. When viewed at a macroscopic level, patterns of LD in The Gambia and
the HapMap Yoruba sample are similar, both for the genome as a whole (Supplementary Fig.
3 online) and for the genomic region around the HbS locus (Supplementary Fig. 4 online).
However, when we attempted to impute rs334 genotypes in our Gambian data using the
HapMap Yoruba as the reference panel, we failed to identify any association signal (P = 0.06).
This may be explained by the fact that the SNP on the Affymetrix array with the strongest LD
with rs334 in The Gambia (rs11036238, r2 = 0.32) has negligible LD in the HapMap Yoruba
samples (r2 = 0.009); conversely, the SNP in strongest LD with rs334 in the HapMap Yoruba
samples (rs7936221, r2 = 0.35) is not in LD with rs334 in The Gambia (r2 = 0.005). This is
consistent with evidence that the HbS allele has arisen independently in different African
populations11,13,14. Although the HbS allele may not be representative of genomic variation
as a whole, it highlights the possibility of local anomalies particularly in regions under strong
selective pressure, and thus raises important questions about the design of an optimal SNP
tagging strategy for African populations in general.
Taken together, these findings support the view that low LD in African populations can help
to distinguish the causal polymorphism from neighboring polymorphisms. But they also
highlight the importance of understanding regional variations in haplotype structure when
designing and interpreting GWA studies in African populations, particularly for loci that are
under selective pressure.
Signals at other known loci
The GWA analysis did not identify any of the well-known erythrocyte variants that have been
selected by malaria, other than HbS. This can partly be explained by population genetic factors;
for example, the Duffy FY*O allele has reached fixation in The Gambia, whereas other variants
such those affecting hemoglobin C and southeast Asian ovalocytosis are rare or absent in this
population. We might have expected associations at G6PD and HBA1-HBA2, the loci for
glucose-6-phosphate deficiency15-17 and α+thalassaemia18-20, respectively, but our GWA
dataset had no SNP within 100 kb of G6PD and only one SNP within 50 kb of HBA1-HBA2.
To investigate G6PD in more detail, we used the Sequenom iPlex platform to genotype
rs1050828, a coding polymorphism that has received considerable attention as a marker of
protection against severe malaria15,17, although there are other polymorphisms associated
with reduced G6PD enzyme activity that have been less well studied in malaria and could
possibly also be involved21. The minor allele frequency of rs1050828 in the Gambian control
sample was 0.03, considerably lower than samples from Kenya (0.18) and Malawi (0.19) that
we genotyped by the same method. Power to detect association with rs1050828 in The Gambia
is affected by this low allele frequency, and the results were consistent with a modest protective
effect but were not statistically significant: odds ratio (OR) for male hemizygotes 0.71 (95%
CI = 0.34–1.49) and for female heterozygotes 0.79 (95% CI = 0.43–1.46). Even if it had been
a strong effect, it would not have given a GWA signal because the best tagging SNP for
rs1050828 on the Affymetrix 500K array had r2 = 0.06.
We also examined the ABO locus, where the functional variant is known and an effect has been
conclusively replicated across different populations22. A previous study combining case-
control and family-based analyses of ~9,000 individuals in three populations found that
individuals who are not of blood group O (as defined by the functional variant rs8176719, a
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splice-site insertion in the ABO gene) have ~1.2-fold increased risk of severe malaria with a
combined P value of 2 × 10−7 (ref. 22). We genotyped rs8176719 in our GWA sample and
found an association that was entirely consistent with previous data (OR = 1.26, 95% 5 CI =
1.11–1.44, P = 5×10−4) but which would our initial GWA significance threshold of P <
10−4. The lack of a GWA signal can be explained by the fact that the best tagging SNP had
r2 = 0.15.
Other SNP associations have been reported for malaria but have not been conclusively
replicated in large studies across different populations, and are mostly thought to be markers
rather than true causal variants. At seven loci (CD36, CD40LG, CR1, ICAM1, IL22, NOS2,
TNF) we genotyped nine candidate SNPs previously reported to show association with malaria
(Supplementary Table 4 online). A weak association was identified at TNF for rs2516486
(P = 0.02) but this did not result in a GWA signal, as the best tagging SNP had r2 = 0.51. Other
SNPs tested showed no significant association, but had they done so it might have been missed
by GWA analysis, as all candidate SNPs were poorly tagged by the Affymetrix 500K array
(median r2 = 0.45; range 0.01–0.61) (Supplementary Table 4).
In summary, the lack of GWA signals corresponding to previously reported malaria
associations can at least in part be explained by low tagging efficiency of the Affymetrix 500K
array in this population and other causes of low statistical power, particularly low allele
frequencies. However these data also raise the question of how many previously reported
associations may have been false positives. In some cases an authentic association may fail to
replicate because the effect size was overestimated in initial reports (‘winner's curse’); because
the frequency of the causal variant varies between populations; because LD between the marker
SNP and the causal variant varies between populations; or because the effect is complex, for
example, due to allelic heterogeneity or epistasis. These issues are currently being addressed
by the MalariaGEN consortium in a multicenter study across 11 different malaria-endemic
populations4.
Loci identified by genome-wide association analysis
From the above analyses it is clear that in the Gambian population the Affymetrix 500K array
may fail to detect authentic resistance loci with weak effects, and that even strong genetic
determinants may give relatively weak GWA signals. In the following analysis we focus
primarily on GWA signals with P-values <10−4, although it will be important to follow up
weaker GWA signals in future work.
We identified 19 regions of the genome in which there were ≥2 SNPs with P< 10−4 or a single
SNP with P< 10−6 (Table 1). Three regions other than HBB had signals of P< 10−6.
Chromosome 2q37 had five SNPs at P< 10−4 with a minimum of P = 5.1×10−7 in a recessive
model: the closest genes are SPATA3, encoding a spermato-genesis-associated protein;
LOC257407, encoding a hypothetical protein; PSMD1, encoding a proteasome subunit; and
GPR55, encoding a G protein–coupled receptor. Chromosome 5p12 had three SNPs at P<
10−4 with a minimum of P = 4.5×10−7 in a heterozygous advantage model: this region has a
number of genes encoding proteins of unknown function. Chromosome 14q21 had three SNPs
at P< 10−4 with a minimum of P = 6.5×10−7 in a dominant model: this area seems to be a gene
desert.
Signal plots for each of the regions listed in Table 1 are shown in Supplementary Figure 5
online. In addition to SNPs that were directly genotyped, Supplementary Figure 6 online
shows imputed genotypes in each of these regions, with the caveat that imputation is based on
the HapMap Yoruba reference panel and this can give erroneous results when applied to the
Gambian population, as we show above for HbS.
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Severe malaria is composed of several overlapping clinical entities, notably cerebral malaria
and severe malaria anemia23,24, and there may be genetic effects that are specific for a
particular subphenotype. We carried out separate principal component–corrected analyses on
the 758 cases with cerebral malaria and 297 cases with severe malaria anemia (97 subjects had
both cerebral malaria and severe malaria anemia). Results of the subphenotype association
tests are included in Supplementary Table 3. Acknowledging the limitation of low sample size,
there is an indication that some GWA signals may be specific for cerebral malaria. They include
two signals of P ~ 10−5, one close to CAMTA1 (encoding calmodulin-binding transcription
activator) and another within RYR2 (encoding a ryanodine receptor involved in calcium-
dependent signaling). These loci are particularly notable in view of the importance of calcium
signaling in cerebral function.
Replication study of severe malaria
We conducted a replication study in an independent sample of 1,087 severe malaria cases and
2,376 controls for a number of loci containing genes of interest (Table 2) and for all of the
listed in Table 1. The replication study used the Sequenom iPlex platform: at some loci it was
not possible to type the SNP with the strongest association in the GWA study by this method.
Analysis of the replication data was stratified by self-reported ethnicity and was integrated
with the PCA-corrected GWA analysis using a weighted combination of linear odds ratios.
The combined sample after application of quality control filters to the GWA data comprised
2,045 cases and 3,758 controls.
At the HBB region on chromosome 11p15.4, a trend test for rs11036238 had OR of 0.61 (P =
3.9 × 10−7) in the GWA study, 0.65 (P = 6.8 × 10−7) in the replication study and 0.63 (95%
CI = 0.55–0.72, P = 3.7 × 10−11) in the combined sample.
A number of newly identified loci that showed notable associations in the combined sample
are described in the Supplementary Note online. The strongest effects were observed on
chromosome 17p13 (rs6503319: trend test OR = 1.21, 95% CI 1.12–1.31, P = 7.2 × 10−7) close
to SCO1, which encodes a protein involved in cytochrome oxidase function; and on
chromosome 7p12.2 (rs1451375: dominant model OR = 0.75, 0.66–0.85, P = 6 × 10−6; and
rs7803788, model OR = 0.76, 0.68–0.85, P = 2.4 × 10−6) intronic to DDC, encoding dopa
decarboxylase, which is involved in dopamine and serotonin synthesis. Notably, DDC has also
been linked to malaria refractoriness in mosquitoes25. Although these findings are of
considerable interest, they cannot be regarded as conclusive until they have been replicated at
multiple study sites. Below we discuss the challenges of multicenter replication studies in
African populations.
DISCUSSION
The application of GWA analysis to populations in Africa could provide fundamental insights
into resistance to infectious disease and the genetic origins of common diseases26. The main
conclusion of the current study is that this will require a different methodological approach
than that used for GWA analysis in European or Asian populations. GWA analysis proceeds
in three stages: first, discovery of regions of the genome with significant associations; second,
multi-center replication studies; and third, fine mapping of causal variants. Here we consider
each of these stages of analysis, and how they might be effectively implemented in Africa.
At the first stage of GWA analysis, screening many SNPs across the genome, a stringent
threshold for statistical significance is used to reduce false-positive rates. There is theoretical
debate about where to set this threshold but take, for example, the level of P < 5 × 10−7 used
by the Wellcome Trust Case Control Consortium in the British population9,27,28. In practice
it is difficult to achieve this threshold in Africa, because of weak LD between the marker SNPs
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that are genotyped and causal variants. We found, for example, that the GWA signal at the
HbS locus barely reaches this level of significance, although the causal variant is common and
confers tenfold reduction in risk of severe malaria. It is likely that there are many authentic
loci with modest genetic effects that are several orders of magnitude below this level of
significance, as we have shown here for the ABO locus.
Multipoint imputation offers a potential solution to this problem. We found that the GWA
signal around the HbS variant can be boosted by several orders of magnitude by imputation,
from P = 3.9 × 10−7 to 4.5 × 10−14. Although GWA signals are often increased =by imputation,
this is a much larger effect than is commonly observed in European populations. It reflects the
fact that no individual marker SNP is strongly correlated with the HbS causal variant but that
it is possible to gather much additional information about the causal variant from haplotypic
combinations. The ability of multipoint imputation to boost a GWA signal is potentially
greatest in situations where there is no single marker SNP that is strongly correlated with the
causal variant, and imputation could therefore be of particular importance in Africa.
Multipoint imputation cannot work effectively without accurate data on sequence variation
and haplotype structure. This is critical in situations of low LD, where a significant proportion
of common variants have no strong marker SNP, as is the case for HbS, and important genetic
effects might be missed if these variants are not genotyped, or accurately imputed, at the first
stage of GWA analysis. The genetic diversity found across Africa increases the imperative for
the data underpinning imputation to be population specific. Population-specific data are needed
because sequence variants and haplotypes can be highly localized within Africa; for example,
the malaria resistance factor hemoglobin C (HbC) is found in some parts of West Africa but
not others29,30.
Development of an optimal genome-wide SNP genotyping platform for use in Africa would
help to strengthen the signals of association that are directly observed at the first stage of GWA
analysis, as well as increase the accuracy of imputation. Although there have been steady
improvements in genotyping platforms since the start of the present study, there is no platform
that achieves genome coverage in Africa that is close to that in Europe31-34; indeed, the number
of SNPs needed to achieve this cannot be precisely estimated until more complete sequencing
information from African populations is available35. From initial HapMap data it was estimated
that 1 SNP per 2 kb in Africa would give approximately the same tagging efficiency as 1 SNP
per 5 kb in Europe, but as more information emerges about sequence variation in Africa, the
estimated number of SNPs required to tag common variants is tending to increase5,35. The
challenge is to determine the optimal number of genotyped SNPs that, when combined with
genome-wide resequencing data from a representative sample of the same population, would
allow accurate imputation of all common variants.
The second stage of GWA analysis is to replicate signals of association in large multicenter
studies. The problem is that replication of association at multiple locations depends on the
allele frequency of the marker SNP and the causal variant, as well as the LD between the marker
SNP and the causal variant, being relatively constant across locations. The high extent of
genetic diversity across Africa therefore creates uncertainty about whether associations with
marker SNPs will replicate at different locations, even if there is a true causal variant. For
example, we find that patterns of LD between the HbS causal variant and surrounding SNPs
vary to such an extent between the Gambian and Yoruba populations that none of the GWA
associations found at the HbS locus in the present study would be expected to replicate across
West Africa. Associations with marker SNPs may also fail to replicate when the causal variant
differs in frequency between locations.
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It is therefore difficult to design effective multicenter replication studies without information
about sequence variation and haplotype structure in the relevant African populations. However,
because the main problem is the variable relationship between marker SNPs and causal
variants, the problem of replication becomes greatly simplified once a shortlist of potential
causal variants has been identified. This is an additional reason to carry out high-resolution
multipoint imputation at the first stage of GWA analysis, as it allows putative causal variants
to be tested directly in different populations.
The third stage of GWA analysis is to identify causal variants. In European populations it can
be extremely difficult to distinguish causal variants from nonfunctional polymorphisms that
are in strong LD with causal variants. This study provides proof of principle that, under the
conditions of low LD found in Africa, it is possible to uniquely identify a causal variant at the
first stage of GWA analysis by multipoint imputation, based on deep sequencing data that are
population specific. Thus, although a considerable amount of work is needed to overcome the
problem of low LD at the initial stages of GWA analysis in Africa, a byproduct of this work
is that it might be possible to proceed relatively rapidly from a GWA scan and replication
studies to the identification of causal variants. The major limiting factor, at all stages of GWA
analysis in Africa, is the need for population-specific data on genome sequence variation. In
the near future, this limiting factor will be overcome by advances in genome sequencing
technologies, through initiatives such as the 1000 Genomes Project.
METHODS
Study sample
The study sample comprised 1,060 cases and 1,500 controls from a mixed urban and rural area
of approximately 400 square miles in the Kombos region of The Gambia. Cases were children
admitted to hospital with severe malaria: they had a median age of 4.3 years and 18% had a
fatal outcome. Controls were newborns recruited from routine births at local health clinics.
The control data were shared with a GWA study of tuberculosis (unpublished data). We could
theoretically achieve a modest increase in power by selecting controls that had gone through
childhood without developing severe malaria, but past medical history is difficult to ascertain
with confidence in this population.
Severe malaria is made up of several overlapping clinical entities23,24,36. The cases analyzed
here included 82% with cerebral malaria, 30% with severe malarial anemia and 11% with
respiratory distress. By estimating the protective effect of the HbAS genotype in this study
sample we can exclude high rates of diagnostic misclassification, which can arise when other
severe diseases mimic the clinical features of severe malaria: we found ORs of 0.12 (95% CI
= 0.07–0.21) for cerebral malaria, 0.10 (0.04–0.24) for severe malaria anemia, 0.08 (0.02–0.38)
for respiratory distress and 0.09 (0.05–0.16) for severe malaria in general. These analyses are
stratified for self-reported ethnic group using the Mantel-Haentzel test. Because the control
group was chosen to represent all births, and because only a minority of children develop severe
malaria, these ORs can be viewed as an estimate of relative risk in the general population.
Sample inclusion criteria
The initial sample set consisted of 1,060 cases of severe malaria and 1,500 controls from the
Kombos region of The Gambia, West Africa. Cases of severe malaria, defined essentially
according to WHO criteria36, were recruited on admission to the Paediatric Department of the
Royal Victoria Hospital in Banjul after obtaining informed consent. The main forms of severe
malaria in Gambian children are cerebral malaria, severe malaria anemia and respiratory
distress23,24. In this study we define cerebral malaria as a Blantyre coma score37 of ≤3,
persisting for >30 min after cessation of a transient seizure or after correction of
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hypoglycaemia, in a child with asexual forms of P. falciparum on blood film and no other
evident cause of coma. Severe malaria anemia is here defined as packed cell volume ≤15%, or
hemoglobin ≤5 g/dl with asexual forms of P. falciparum on blood film. Controls were cord
blood samples obtained from routine births at local health clinics in the Kombos region after
obtaining informed consent. The study was approved by The Gambia Government/Medical
Research Council Joint Ethics Committee and by the Oxford Tropical Research Ethics
Committee. Ethics approval documents and informed consent forms are available upon request.
Imputation
The program IMPUTE10 was used to infer the genotypes of SNPs in the Yoruba panel of the
International HapMap Project. To avoid SNPs with genotyping errors in the Gambian study,
we used only SNPs on the Affymetrix platform for the Gambian data with minor allele
frequency >41% and missingness <5% in both case and control cohorts, and with Hardy-
Weinberg equilibrium P ≥ 10−7 in controls as the input for IMPUTE. The results from IMPUTE
were used in our association study in two ways: (i) the same spectrum of association tests was
conducted at each imputed SNP where, for each individual, the genotype corresponding to the
maximum posterior probability is assigned unless this probability is <0.9 and a missing
genotype is assigned instead; (ii) the same spectrum of association tests was conducted at each
imputed SNP where the posterior probabilities of the calls are used to average over the
uncertainty in the inference of the genotypes. In the former analysis, only imputed SNPs that
satisfy the genome-wide SNP quality control criteria (see ‘SNP filters’ in Supplementary
Methods online) were considered; in the latter analysis, only imputed SNPs with relative
statistical information >0.5 were considered.
Sequencing in the beta-globin region
The beta-globin region was sequenced in 62 randomly selected Gambian control individuals
who had previously been genotyped on the Affymetrix 500K array. The sequenced region spans
110 kb from 5,179,297 to 5,289,530, and encompasses all five beta-globin genes (HBB,
HBD, HBE1, HBG1, HBG2) and an olfactory receptor (OR51B1). To avoid false positives
introduced by sequencing errors and as the underlying interest here is in detecting malarial
association with common polymorphisms, we only define a polymorphic marker if the minor
allele frequency of this marker exceeds 5% or, equivalently, if at least 4 minor alleles out of
the 124 chromosomes are observed. On the basis of this definition we identified 202 SNPs in
the sequenced region (66 of which were previously unknown SNPs), although we expect the
true number to be higher.
To avoid edge effects in haplotype phasing and imputation, the data for each sequenced sample
was extended by including SNPs from the Affymetrix array flanking both ends of the sequenced
region, creating a 1-Mb region centered on rs334 (at 5,204,808 in build 35) from 4,705,000 to
5,705,000 spanning 453 SNPs in total. Haplotypes for this 1-Mb region were constructed using
fastPHASE38, and were subsequently used as the reference panel for imputation using
IMPUTE10.
Genotypes for all 453 SNPs in this 1-Mb region were imputed across the remaining 1,325
controls and all 958 cases. We carried out tests for malaria association on all the imputed SNPs
and the results from the trend test are shown in Figure 5 as red dots. Association results for
SNPs on the Affy 500K array are shown in black. Rather than threshold the imputed calls with
a missingness filter, the association test averages over the imputation uncertainty by using the
genotype posterior probabilities from the imputation. As before, the first three principal
components estimated from the array genotypes using EIGENSTRAT were included as
covariates in the test for association.
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Additional description of the DNA handling protocol, data quality control and analytical
methodologies can be found in the Supplementary Methods and Supplementary Figures 7–
10 online.
URLs
MalariaGEN, http://www.malariagen.net.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Principal components analysis of population structure within The Gambia. Plots of the first
three principal components from EIGENSTRAT using 100,715 SNPs selected to minimize
intermarker LD. Each solid circle represents an individual, and the color is assigned according
to self-reported ethnicity. (a) Plot of the first two principal components for all Gambian
samples. (b) Plot of the second and third principal component for all Gambian samples.
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Figure 2.
Principal components analysis of population structure for the Gambian study sample in relation
to HapMap reference panels. Plots of the first two principal components from EIGENSTRAT
using 100,715 SNPs selected to minimize intermarker LD. Each solid circle represents an
individual. (a) Plot of the first two principal components for HapMap and Gambian samples.
(b) Plot of the first two principal components for HapMap YRI and Gambian samples.
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Figure 3.
Quantile-quantile plots of association test statistic. (a–c) Quantile-quantile plots of the trend
test statistic for the unstratified analysis, which uses all 958 cases and 1,382 controls (a); the
ethnic-stratified analysis, which tests 854 cases, 1,195 controls from the four major ethnic
groups (b); and the PCA analysis, which corrects for the first three principal components from
EIGENSTRAT and uses all 958 cases and 1,382 controls (c). The shaded region in gray
represents the lower and upper 95% probability bounds for the expected quantiles.
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Figure 4.
Genome-wide signals of association with severe malaria. Plot of the −log10 P values for the
trend test correcting for the first three principal components from EIGENSTRAT. Each point
represents a SNP from the 402,814 remaining after quality control filters were applied.
Different bands of blue are used to differentiate SNPs on consecutive autosomal chromosomes.
SNPs with P values less than 10−4 are represented by red points.
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Figure 5.
Association signal at the HBB locus. The top panel shows the association signals across a 1-
Mb region on chromosome 11 centering on rs334, with the vertical axis representing the
−log10 P values from the Armitage trend test. Points in black represent SNPs that are found on
the Affymetrix array, and points in red represent SNPs imputed with the resequenced Gambian
reference panel. The dashed lines in red indicate the start and end of the sequenced region. The
bottom panels focus on the 110-kb sequenced region, together with a map of the recombination
rates and genes found in the region. Recombination rates and genes were extracted from the
HapMap Genome Browser.
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Figure 6.
Extent of LD surrounding HbS. Each point show r2 (top panel) and D' (bottom panel) between
the HbS SNP (rs334) and SNPs in the Gambian reference panel. The shaded pink region
indicates the boundaries of the resequenced region. The dashed vertical line indicates the
position of rs334.
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